Bone-marrow-derived (B) and thymus-derived (T) lymphocytes can be distinguished by the presence of a number of receptors and differentiation antigens. The presence of these markers has facilitated the identification and characterization of the mononuclear cells in a number of animal and human lymphoid malignancies. We describe here the immunological properties of human leukemia cells that are highly unusual, since they simultaneously bear the receptor for sheep erythrocytes characteristic of human T lymphocytes and the receptor for antigen-antibody-complement complexes characteristic of human B lymphocytes. A small number (about 2%) of normal human lymphocytes bearing both of these receptors was also identified.
The mononuclear cells participating in immune responses are heterogeneous both morphologically and functionally. Over the last few years a number of receptors and differentiation antigens have been identified on the different classes of immunologically competent cells. The bone-marrow-derived, B lymphocyte, can be identified by the presence of easily detectable surface immunoglobulin (SIg) (1), a receptor for antigen-antibody-complement complexes (EAC) detected by using red cells (E) coated with antibody (A) and complement (C) (2) , and a receptor for the Fc portion of IgG which can be detected with soluble antigen-antibody complexes (3) or by using fluorescein-labeled aggregated IgG (4) . Murine thymus-derived, T lymphocytes, can be detected by the presence of the theta alloantigen (5) , while human T lymphocytes can be detected by their ability to form nonimmune rosettes with sheep red blood cells (SRBC) (6) or by using fluoresceinlabeled anti-T cell antibodies (7) . It is likely that SIg functions as the specific antigen receptor on the B-cell surface; the immunological significance of the EAC and Fc receptors is as yet unknown although a number of hypotheses have been advanced to explain their roles in the immune response (8) .
No explanation has been offered for the binding of SRBC by human T cells, but similar receptors have been identified on the T cells of other species (9) .
Even though the specific functional role of these receptors is as yet unknown, their presence or absence on mononuclear cells of unknown type is a valuable tool for the identification and characterization of mononuclear cells in a variety of Abbreviations: SIg, surface immunoglobulin; EA, erythrocyteantibody complexes; EAC, erythrocyte-antibody-complement complexes; B lymphocyte, bone-marrow-derived lymphocyte; T lymphocyte, thymus-derived lymphocyte; CLL, chronic lymphatic leukemia; WBC, white blood cell; E, erythrocyte; SRBC, sheep red blood cell. malignant, infectious and immunologic diseases (10) . For example, the cells from the majority of patients with chronic lymphatic leukemia (CLL) have been demonstrated to bear SIg (11), the EAC (12), and Fc receptors (13) , and to fail to form E rosettes (14) ; CLL is therefore a B-cell malignancy. In contrast, the cells from patients with Sezary's syndrome, a disease complex consisting of erythroderma and morphologically distinctive cells in the peripheral blood (15) , lack SIg and the EAC receptor, but do form E rosettes (16, 17) ; Sezary's syndrome is therefore a T-cell malignancy. In this communication, we describe the morphologic and immunologic characteristics of the cells from a patient with chronic leukemia that were found to simultaneously bear cell surface receptors of both B and T cells.
MATERIALS AND METHODS
Summary of Clinical Course. The patient, F.S., a 64-yearold female, developed a generalized eczematous dermatitis approximately 9 years before admission to the NIH on 3/19/ 73. Four years before admission her WBC (white blood cell) count rose to greater than 20,000/mm3 with lymph node and marrow involvement by mature lymphocytes, and a diagnosis of CLL was made. During the present study, her WBC count increased to greater than 300,000/mm3, and her cutaneous disease progressed to an exfoliative erythroderma.
Separation of Peripheral Blood Lymphocytes. Lymphocytes were obtained from the peripheral blood of normal volunteers by the use of the Hypaque-Ficoll technique (18 suspension was then examined in a hemacytometer chamber and the number of white blood cells with three or more red cells adherent (rosettes) determined; the total number of WBC was simultaneously counted and the percent of WBCforming rosettes calculated. A minimum of 200 lymphocytes were counted in each preparation.
Detection of E Rosette-Forming Cells. A modification of the method of Weiner et al. (21) was used. SRBC were treated with neuraminidase from Clostridium perfringens (Sigma Chemical, St. Louis, Mo.) and adjusted to a concentration of 1 X 108/ml in RPMI-1640. Equal volumes of the neuraminidase-treated SRBC were mixed with normal lymphocytes or leukemia cells at a concentration of 3 to 4 X 106/ml and incubated at 370 for 15 min; the suspensions were then spun at 200 X g for 10 min and the supernatant gently removed and replaced with 100% fetal-calf serum which had been previously absorbed with SRBC. After an 18-hr incubation at 40, the pellet was gently resuspended and the number of cells forming rosettes enumerated as described above for detection of the EAC receptor.
Simultaneous Detection of EAC and E Rosettes. Two different methods were used for the simultaneous detection of EAC-and E-binding cells. In the first method the EAC and E receptors were detected using fluorescein conjugated SRBC (6) for the preparation of one reagent and rhodamine conjugated SRBC for the other reagent. In order to prevent any potential E rosette formation by the SRBC in the EAC reagent, the SRBC were first treated with a 2 mg/ml of solution of trypsin (Nutritional Biochemicals, Cleveland, Ohio) as described by Weiner et al. (21) . In the second method guinea pig red cells were used to form the EAC reagent because unsensitized guinea pig red cells do not form rosettes with human T cells. The EAC, E, and mixed rosettes were then easily distinguished by the larger size of the guinea pig red cells and also in selected experiments by differential labeling of the indicator red cells with either fluorescein or rhodamine. In detail, to detect EAC and E rosettes simultaneously, equal volumes of lymphocytes, E, and EAC were mixed at 370 for 30 min; the suspension was then spun at 200 X g for 10 min and the supernatant removed and replaced by 100% fetal-calf serum. After an 18-hr incubation at 40 the percent of lymphocytes forming EAC, E, and mixed EAC and E rosettes was determined using a Leitz ortholux microscope equipped with tungsten and ultraviolet illumination. 
RESULTS
Morphology of the Leukemic Cells. Fig. 1 illustrates the morphologic findings of the cells in CLL, the Sezary syndrome (small cell variant) and in patient F.S. In chronic lymphatic leukemia (Fig la) the lymphocytes are small and have sparse cytoplasm with a smooth round nucleus; dense heterochromatin is clumped at the nuclear membrane. In the Sezary syndrome (Fig. lb) , the nucleus is serpentine and convoluted. The nucleocytoplasmic ratio is high, and the cytoplasm appears normal. The cells from patient F.S. (Fig. lc) DISCUSSION Bone-marrow-derived and thymus-derived lymphocytes can be distinguished by the presence of a number of receptors and differentiation antigens. The presence of these markers has facilitated the identification and characterization of the mononuclear cells in a number of animal and human lymphoid malignancies. Two types of chronic leukemia in man have recently been delineated based on the morphological and immunological characteristics of the cells involved. One type is seen in patients with "classic" CLL; these cells frequently bear SIg, the EAC and Fc receptors, and do not form E rosettes. The second type of leukemia is seen in patients with erythroderma; these cells have a high nucleocytoplasmic ratio, a grooved and folded nucleus, and are termed Sezary cells. Large and small cell variants of the Sezary cells have been described (24) , but both varieties lack SIg and to date all reported cases form E rosettes and are presumably of Tcell origin (16, 17) . Although the clinical course of the patient described here resembles that of a patient with Sezary's syndrome, the ultrastructural morphology of her leukemia cells is unique and can readily be distinguished from both of the Sezary syndrome variants and from CLL cells. These cells are also highly unusual since they bear the E-receptor characteristic of human T lymphocytes and the EAC-receptor characteristic of human B lymphocytes. It therefore appears that this patient has neither classical CLL or Sezary syndrome but rather a previously underscribed disease entity.
A single malignant lymphoid tumor cell with surface receptors characteristic of both B and T cells has been identified in the mouse (25) . This lymphoid tumor line (WEH-22.1) bears large quantities of cell-surface IgM, the Fc receptor, and the theta alloantigen. Although it is likely that the human leukemia cells described in this report also bear receptors characteristic of both B and T cells, one possible explanation for the properties of the cells observed in that the leukemia cells represent a malignant clone of B lymphocytes with immunologic specificity (antigen-binding activity) for SRBC. However, these cells would then bind the SRBC via cell-surface immunoglobulin and no immunoglobulin could be identified on the surface of the leukemia cells. It should also be noted that a high percentage of the leukemia cells could be lysed by a specific heterologous anti-human T cell serum (27) that under the conditions used to detect mixed EAC and E rosettes (an initial incubation at 370 followed by a longer incubation at 40), EAC rosettes form first at 37°while E rosettes only form at 4°. Therefore, if large erythrocytes are used to first form EAC rosettes, the subsequent binding of the smaller SRBC in the E reagent may be sterically hindered. Although we did observe mixed EAC and E rosettes with the EAC composed of the larger guinea pig erythrocytes, the detection of mixed rosettes was greatly facilitated by using SRBC in both the EAC and E reagents. In these studies the reagents were labeled with either fluorescein or rhodamine to distinguish the two types of rosettes and the cells used in the preparation of the EAC reagent were first trypsin treated to remove their ability to form E rosettes.
Although the presence of cells simultaneously bearing SIg and the E receptor was not observed in the study of Jondal et al. (6) , Bentwich et al. (14) , and Dickler et al. (28) have recently reported the existence of both SIg and/or the Fc receptor as well as the E receptor on 2-4% of normal human peripheral blood lymphocytes. The presence of the EAC receptor was not studied by these investigators. Although the existence of 2-4% of cells in normals with double markers might be ascribed to a technical artifact of the methods used, this cannot be the explanation for the high percentage of mixed rosettes observed in the leukemia cells described in this study. Therefore, the observations made on these leukemia cells suggest that the finding of a low percentage of cells with double markers in normals in real. Indeed, it is likely that the leukemia cells arose from this normal "hybrid" population. Alternatively, it is possible that the dual properties of these leukemia cells are a manifestation of the disordered differentiation of the malignant state.
There is ample functional evidence that B cells, T cells, and macrophages interact with antigen and that these cells cooperate in the immune response (26) ; however, the physical and molecular basis of this cooperation remains obscure. Since B cells and macrophages have Fc and EAC receptors and as we have shown here a subpopulation of T cells also has the EAC receptor, the binding of immune complexes to these receptors may be one of the mechanisms for bringing together all three cell types. The special functional significance and the role in the immune response of cells with properties of both B and T cells must remain a subject for speculation and further study.
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